Franklin College Partners with B2s Life Sciences to Launch the B2s Life Sciences Career Development Fellowship

By Franklin College | | 1.27.25

Franklin College and B2S Life Sciences are excited to announce the creation of the B2S Life Sciences Career Development Fellowship, a new initiative designed to enrich students' academic experience with essential real-world exposure to life science research and high-tech industries. The 3-year scaffolded fellowship experience will bridge the gap between academic preparation and a successful career transition upon graduation.

“We are deeply grateful to B2S for their generous and ongoing support of the educational experience for our students,” said Franklin College President Kerry N. Prather. “The commitment of B2S to enhancing academic opportunities by providing practical experience has had a profound impact on the careers of many students. Through this expanded support, our students will be empowered to pursue their passion in the life sciences, develop critical skills and immerse themselves in the industry. We are proud to partner with B2S in preparing the next generation of leaders in the life science sector of the economy.”

“We are excited to deepen our commitment to developing future leaders in life sciences through the B2S Life Sciences Career Development Fellowship,” said Aleks Davis, CEO of B2S Life Sciences. “This fellowship program reflects our dedication to not only advancing scientific innovation but also fostering talent by equipping students with the practical skills and experiences needed to succeed in today’s competitive job market. Partnering with Franklin College in this endeavor aligns with our vision to bridge academic learning and industry demands, creating a lasting impact on students’ professional journeys.”

B2S Fellows will work alongside professionals in an entrepreneurial research and development environment, gaining hands-on training in areas crucial to the development of new biotherapeutics. Students will also develop collaborative team-working skills, which are critical in modern research and development settings.

The student selected to pilot the fellowship is Alecia Perkins, a sophomore from Franklin, Indiana. Perkins is a biology and biomedical science major.

“I’m very excited to be chosen for this fellowship opportunity,” Perkins said. “Working with the excellent scientists at B2S will only broaden my knowledge and passion for the field of science. I can’t express how grateful I am for this opportunity and all the possibilities it may lead to in the future.”

The fellowship provides structured, long-term experience to ensure students acquire the practical skills needed for today’s competitive high-tech job market. The program provides a $5,000 scholarship annually per student for up to three years, totaling $15,000 per student. B2S Fellows may also earn internship credits toward graduation requirements.

The fellowship is tailored to a wide range of professional aspects of life science research and related fields, including lab research, business functions, mathematical sciences, and information technology.

Franklin College will nominate a pool of qualified candidates for consideration each year. The selection of fellows will be conducted by B2S Life Sciences through a competitive application and interview process.

Each fellow will be guided by a mentor from B2S Life Sciences, who will oversee professional development and technical training throughout the program.

About B2S Life Sciences

B2S Life Sciences is a leading biotechnology company focused on delivering advanced solutions in biotherapeutic research and development. Specializing in bioanalytical, translational, and biomarker research, B2S partners with biopharmaceutical organizations to support the discovery, development, and commercialization of innovative therapies. With a commitment to quality and scientific precision, B2S stands at the forefront of the life sciences industry, providing expertise in assay development, data-analytical services, and critical reagent production that drive forward advancements in drug development.